Hosted on MSN11mon
AstraZeneca will cap inhaler costs at $35 per monthAstraZeneca is capping out-of-pocket costs for inhalers and related medication at no more than $35 per month, the drugmaker announced Monday. The Britain based pharma giant said the expanded ...
(The Hill) — Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday. The cap is effective June 1 and will apply to the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback